Pancreatic Cancer Research

ResearcherGuangxi Medical UniversityActive in the last 2 years

Hongquan Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5447-2017; OpenAlex author ID A5100733620. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 4

  1. KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41420-024-02020-4↗
  2. Progress on diagnostic and prognostic markers of pancreatic cancer. Co-author DOI 10.32604/or.2023.028905↗
  3. The m6A demethylase ALKBH5-mediated upregulation of DDIT4-AS1 maintains pancreatic cancer stemness and suppresses chemosensitivity by activating the mTOR pathw… Co-author DOI 10.1186/s12943-022-01647-0↗
  4. Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF. Co-author DOI 10.20892/j.issn.2095-3941.2022.0299↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yan Wang · 3 shared papers, 2022–2024 · strength 0.60
  2. Bo Tang · 1 shared paper, 2022 · strength 0.22
  3. Yumin Wang · 1 shared paper, 2024 · strength 0.22
  4. Bo Tang · 1 shared paper, 2024 · strength 0.22
  5. Bo Tang · 1 shared paper, 2023 · strength 0.16
  6. Guanhua DU · 1 shared paper, 2023 · strength 0.16
  7. Hong Yang · 1 shared paper, 2023 · strength 0.16
  8. Jinhua Wang · 1 shared paper, 2023 · strength 0.16
  9. Yi Zhang · 1 shared paper, 2022 · strength 0.16
  10. Xiaomeng Liu · 1 shared paper, 2022 · strength 0.16
  11. Bo Tang · 1 shared paper, 2022 · strength 0.16
  12. Shihui Lai · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.